Thomas Lundbäck

18PUBLICATIONS
66CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsPharmaceutical delivery technologiesBiologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 19, 2026
The rise and fall of SARM1 base-exchange inhibitors.

|Jan 12, 2026
Systematic Application of a Cellular Thermal Shift Assay for Inferring Inhibitor Binding Affinity to 17βHSD13 in a Humanized Liver Homogenate.

Sandra Lunnerdal, Fredrik Wågberg, Göran Dahl

|Feb 28, 2025
Targeting TUBG1 in RB1-negative tumors.

Lisa Lindström, Jingkai Zhou, Bruno O Villoutreix

|Nov 08, 2024
Closing the Design-Make-Test-Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability.

Zulma Santisteban Valencia, Jennifer Kingston, Filip Miljković

|May 10, 2024
All-photonic kinase inhibitors: light-controlled release-and-report inhibition.

Cassandra L Fleming, Carlos Benitez-Martin, Elin Bernson

|Feb 13, 2024
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus.

Masum Miah, Andrew M Davis, Charles Hannoun

Pageof 3

Frequent Collaborators

3 joint publications

Johan Wernevik

2 joint publications

Silvio Di Castro

2 joint publications

Morten Grøtli

2 joint publications

M Paola Castaldi